Please login to the form below

Not currently logged in
Email:
Password:

David Khougazian appointed president of Sanofi Pasteur MSD

He will succeed Dr Jean-Paul Kress atthe Sanofi Pasteur - Merck & Co venture

Sanofi Pasteur MSD David KhougazianSanofi Pasteur MSD has appointed David Khougazian as its new president, a role he will take up on September 1, when he will succeed Dr Jean-Paul Kress at the Sanofi Pasteur - Merck  & Co venture.

Kress, who has led the company since July 2011, will then leave Sanofi Pasteur MSD to join the Sanofi group - which recently announced a major restructuring of its business.

Khougazian moves to the vaccines-focused firm from a position as Sanofi CEO chief of staff, which he held since 2011.

Prior to this he had a number of business operations positions in sales and marketing and as general manager, having joined Rhône-Poulenc (now part of Sanofi) in 1997.

Olivier Charmeil, president and CEO of Sanofi Pasteur, said: “Sanofi Pasteur MSD is a major player in the European vaccines market. David's appointment marks a new phase in our development in Western Europe; a challenging and strategic region for our vaccines activity.

“His knowledge of European markets and external stakeholders will be a strong asset to grow Sanofi Pasteur MSD's position in Europe.”

23rd July 2015

From: Research, Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

How ‘Greenwashing’ accusations could delay the very changes its supporters demand
Are shouts of companies ‘greenwashing’ to provide a façade of environmental and ethical respectability causing more harm than good? Or should we call out practices that we believe are papering...
What does the future hold for clinical trial recruitment?
The past couple of years have raised several aspects of healthcare in the public’s consciousness – and one of the leading ones has been the role of clinical trials in...
When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...